Elisabeth Jones

1.4k total citations · 1 hit paper
5 papers, 1.0k citations indexed

About

Elisabeth Jones is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Transplantation. According to data from OpenAlex, Elisabeth Jones has authored 5 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Transplantation. Recurrent topics in Elisabeth Jones's work include TGF-β signaling in diseases (2 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Prostate Cancer Treatment and Research (2 papers). Elisabeth Jones is often cited by papers focused on TGF-β signaling in diseases (2 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Prostate Cancer Treatment and Research (2 papers). Elisabeth Jones collaborates with scholars based in United States, Australia and Italy. Elisabeth Jones's co-authors include Peter Boyle, Ryszard Gellert, Lawrence Y. Agodoa, Patrick Maisonneuve, Albert B. Lowenfels, Margaret McCredie, Douglas Briggs, Robert A. Wolf, John H. Stewart and Natasha Kyprianou and has published in prestigious journals such as The Lancet, Cancer Research and Soil Biology and Biochemistry.

In The Last Decade

Elisabeth Jones

5 papers receiving 997 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

1999 657 citations Patrick Maisonneuve, Lawrence Y. Agodoa et al. The Lancet profile →

Peers

Elisabeth Jones

NEPHR

PRM

ONCOL

MB

EPIDE

Douglas Briggs United Kingdom

Laura Cosmai Italy

Zheng Tang China

Hideki Ishida Japan

E. Cassuto‐Viguier France

Joseph Weisstuch United States

Koki Mise Japan

Anna M. Leliveld Netherlands

Massimo Iacobelli United States

Thomas Robert France

Douglas Briggs United Kingdom

Elisabeth Jones

361 ×1.1

NEPHR

271 ×0.9

PRM

219 ×0.8

ONCOL

128 ×0.6

MB

166 ×1.0

EPIDE

Citations per year, relative to Elisabeth Jones Elisabeth Jones (= 1×) peers Douglas Briggs

Countries citing papers authored by Elisabeth Jones

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Jones more than expected).

Fields of papers citing papers by Elisabeth Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Jones. The network helps show where Elisabeth Jones may publish in the future.

Co-authorship network of co-authors of Elisabeth Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Jones. A scholar is included among the top collaborators of Elisabeth Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Jones. Elisabeth Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Pu, Hong, et al.. (2009). Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model. Cancer Research. 69(18). 7366–7374. 47 indexed citations

2.

Jones, Elisabeth, Hong Pu, & Natasha Kyprianou. (2009). Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression. Expert Opinion on Therapeutic Targets. 13(2). 227–234. 89 indexed citations

3.

Maisonneuve, Patrick, Lawrence Y. Agodoa, Ryszard Gellert, et al.. (2000). Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. American Journal of Kidney Diseases. 35(1). 157–165. 226 indexed citations

4.

Maisonneuve, Patrick, Lawrence Y. Agodoa, Ryszard Gellert, et al.. (1999). Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. The Lancet. 354(9173). 93–99. 657 indexed citations breakdown →

5.

Jones, Elisabeth. (1983). The politics of agricultural research. Soil Biology and Biochemistry. 15(5). 623–623. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact